Marked chromogranin A elevation in a patient with bilateral adrenal incidentalomas, and its rapid normalization after discontinuation of proton pump inhibitor therapy [1]

Clinical Endocrinology

Volumn 67, Issue 5, 2007, Pages 805-806

  Igaz, Peter ^a   Müllner, Katalin ^a   Hargitai, Beáta ^a   Igaz, Ivan ^b   Tömböl, Zsófia ^a   Rácz, Károly ^a   Tulassay, Zsolt ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UZSOKI HOSPITAL   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A; LANSOPRAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; SUCRALFATE;

ADRENAL INCIDENTALOMA; AGED; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOGRAPHY; ENDOCRINE DISEASE; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; HUMAN TISSUE; HYPERTENSION; LETTER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; SINGLE DRUG DOSE; STOMACH BIOPSY;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADRENAL GLAND NEOPLASMS; AGED; CHROMOGRANIN A; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; FEMALE; HUMANS; PHEOCHROMOCYTOMA; PROTON PUMP INHIBITORS; TUMOR MARKERS, BIOLOGICAL;

EID: 35448967427     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.02957.x     Document Type: Letter

References (5)

1. Giovanella, L., La Rosa, S., Ceriani, L., Uccella, S. Garancini, S. (1999) Chromogranin A as serum marker of neuroendocrine tumors: comparison with neuron-specific enolase and correlation with immunohistochemical findings. International Journal of Biological Markers, 14, 160 166.
2. Grossrubatscher, E., Dalino, P., Vignati, F., Gambacorta, M., Pugliese, R., Boniardi, M., Rossetti, O., Marocchi, A., Bertuzzi, M. Loli, P. (2006) The role of chromogranin A in the management of patients with phaeochromocytoma. Clinical Endocrinology, 65, 287 293.
3. Lenders, J.W.M., Eisenhofer, G., Mannelli, M. Pacak, K. (2005) Phaeochromocytoma. Lancet, 366, 665 675.
4. Giusti, M., Sidoti, M., Augeri, C., Rabitti, C. Minuto, F. (2004) Effect of short-term treatment with low dosages of the proton-pump inhibitor omeprazole on serum chromogranin A levels in man. European Journal of Endocrinology, 150, 299 303.
5. Sanduleanu, S., Stridsberg, M., Jonkers, D., Hameeteman, W., Biemond, I., Lundqvist, G., Lamers, C. Stockbrügger, R.W. (1999) Serum gastrin and chromogranin A during medium- and long term acid suppressive therapy: a case-control study. Alimentary Pharmacology & Therapeutics, 13, 145 153.